Pyronaridine Phosphate

磷酸咯萘啶

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NamePyronaridine Phosphate

Drug Alias NamepyronaridinumpyronaridinepironaridinaM-PA01PANDA

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHemozoin inhibitors

TargetsHemozoin

Therapy Area/IndicationsLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySenegalMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesArmaceutica Inc

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMalaria

Inactive IndicationsN/A

ATC CodeP01B